Noxopharm News and Activities

View the org chart displaying its 7 main executives

Most searched biographies at Noxopharm

• Olivier Laczka, Chief Executive Officer
• Frederick Bart, Non-Executive Chairman of the Board
• Boris Patkin, Director

Popular executive movements at Noxopharm

• Shawn van Boheemen who was Chief Financial Officer, becomes Chief Financial Officer and Company Secretary  (posted on May 4 2026).
• David Franks, Company Secretary and Director, has left the company  (posted on May 4 2026).
• Olivier Laczka, who was Chief Scientific Officer, Inflammation, is promoted to Chief Executive Officer  (posted on April 15 2026).

Click here to view some more movements at Noxopharm

Create your alert
to follow the executive moves at Noxopharm.

Noxopharm has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Noxopharm

• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• Investors | Noxopharm
• View more press releases Close

Social media about Noxopharm

• Noxopharm on Wikipedia, Google News & Yahoo Finance
• Noxopharm on LinkedIn, X (Twitter) & YouTube